Literature DB >> 1483259

Early manifestations of induced prostate tumors in Lobund-Wistar rats.

M Pollard1, P H Luckert.   

Abstract

Lobund-Wistar (L-W) rats are susceptible to spontaneous and induced metastasizing prostate cancer. In the search for the initial site of tumor development in the induced disease, rats at risk were examined periodically to acquire this information. In the course of 12 months after the onset of the induction of prostate cancer in L-W rats, 14 of 40 rats (35%) developed visible tumors in the anterior and in the dorso-lateral lobes of the gland. The prostate tumors appeared at 7 months and thereafter. Two of the tumor-bearing rats had developed, in addition, a visible neoplasm in the seminal vesicle. None of the rats with small early tumors had developed visible metastatic tumors, which were manifested in rats with large tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483259     DOI: 10.1016/0304-3835(92)90133-g

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines.

Authors:  J M Bentel; M A Pickering; M Pollard; J A Clements; W D Tilley
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  The effects of aging on the molecular and cellular composition of the prostate microenvironment.

Authors:  Daniella Bianchi-Frias; Funda Vakar-Lopez; Ilsa M Coleman; Stephen R Plymate; May J Reed; Peter S Nelson
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

3.  Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.

Authors:  Malgorzata Kamocka; Morris Pollard; Mark Suckow; Wojciech P Mielicki; Elliot D Rosen
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

4.  Age-related histopathological lesions in the Mongolian gerbil ventral prostate as a good model for studies of spontaneous hormone-related disorders.

Authors:  Silvana Gisele Pegorin Campos; Cristiani Zanetoni; Wellerson Rodrigo Scarano; Patrícia Simone Leite Vilamaior; Sebastião Roberto Taboga
Journal:  Int J Exp Pathol       Date:  2008-02       Impact factor: 1.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.